Awareness About Glaucoma and Associated Factors Among Glaucoma Patients Visiting Munawar Memorial Hospital Chakwal
Awareness About Glaucoma and Associated Factors
DOI:
https://doi.org/10.54393/tt.v5i01.185Keywords:
Glaucoma, Family History, BlindnessAbstract
Glaucoma is a significant public health problem worldwide blindness after cataract is attributed to this ophthalmic disease. The resultant blindness is mostly irreversible. Its earlier detection is imperative to prevent blindness. Objective: To ascertain the awareness about glaucoma and associated factors among glaucoma patients in association with family history. Methods: A cross-sectional descriptive hospital base study was done among 21 glaucoma patients at Munawar Memorial Hospital Chakwal from October – December 2021. The patients were enrolled through consecutive sampling. Data were gathered from the patients through self-structured questionnaire pertaining to demographics, family history, association of glaucoma with blindness, reversibility of resultant blindness, treatment in addition to prevention and cure of blindness. Data were analysed by SPSS version 25.0. Apart from descriptive statistics, Fisher’s exact test was also applied to measure the association of family history of glaucoma with other factors. p<0.05 was taken as significant. Results: Of the 21glaucoma patients, most (63%) were males and 11 patients had positive family history. Overall, 25% patients knew about the disease. Mean age of the respondents was 50.52 ± 22.5 years. Almost 72.2% of the patients with positive family history were aware about the prevention of blindness resulting from glaucoma (p<0.05). on the other hand, 81.8% of the patients with negative family knew about cure. 81.8% of the patients knew the purpose of treatment (p<0.05). Conclusions: There was scarcity of knowledge about glaucoma among patients. Despite the positive family history, knowledge of glaucoma patients about their disease was deficient.
References
Harasymowycz P, Birt C, Gooi P, Heckler L, Hutnik C, Jinapriya D et al. Medical management of glaucoma in the 21st century from a Canadian perspective. Journal of Ophthalmology. 2016 Nov; 2016: 6509809. doi: 10.1155/2016/6509809.
Weinreb RN, Leung CK, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL et al. Primary open-angle glaucoma. Nature Reviews Disease Primers. 2016 Sep; 2(1): 1-9. doi: 10.1038/nrdp.2016.67.
Thomas S, Hodge W, Malvankar-Mehta M. The cost-effectiveness analysis of teleglaucoma screening device. PloS one. 2015 Sep; 10(9): e0137913. doi: 10.1371/journal.pone.0137913.
Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma Lancet, 390 (10108) (2017). View PDF View article View in Scopus: 2183-93. doi: 10.1016/S0140-6736(17)31469-1.
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov; 121(11): 2081-90. doi: 10.1016/j.ophtha.2014.05.013.
Lin S. Glaucoma in Asian populations. [Last cited: 24th Jan 2024]. Available at: https://glaucoma.org/glaucoma-in-asian-populations/.
Bourne RR, Taylor HR, Flaxman SR, Keeffe J, Leasher J, Naidoo K et al. Number of people blind or visually impaired by glaucoma worldwide and in world regions 1990–2010: a meta-analysis. PloS One. 2016 Oct; 11(10): e0162229. doi: 10.1371/journal.pone.0162229.
Nkum G, Lartey S, Frimpong C, Micah F, Nkum B. Awareness and knowledge of glaucoma among adult patients at the eye clinic of a teaching hospital. Ghana Medical Journal. 2015; 49(3): 195-9. doi: 10.4314%2Fgmj.v49i3.11.
Mukamal R. Common drugs that can worsen glaucoma. [Last cited: 24th Jan 2024]. Available at: https://www.aao.org/eye-health/tips-prevention/dangerous-medications-glaucoma-dayquil-bendadryl.
Dada T, Verma S, Gagrani M, Bhartiya S, Chauhan N, Satpute K et al. Ocular and Systemic Factors Associated with Glaucoma. Journal of Current Glaucoma Practice. 2022 Sep; 16(3): 179. doi: 10.5005%2Fjp-journals-10078-1383.
Langman MJ, Lancashire RJ, Cheng KK, Stewart PM. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence. The British Journal of Ophthalmology. 2005 Aug; 89(8): 960. doi: 10.1136/bjo.2004.053397.
Wolters TL, Roerink SH, Drenthen LC, van Haren-Willems JH, Wagenmakers MA et al. The course of obstructive sleep apnea syndrome in patients with acromegaly during treatment. The Journal of Clinical Endocrinology & Metabolism. 2020 Jan; 105(1): 290-304. doi: 10.1210/clinem/dgz050.
Fujita A, Hashimoto Y, Matsui H, Yasunaga H, Aihara M. Association between lifestyle habits and glaucoma incidence: a retrospective cohort study. Eye. 2023 Apr: 1-7. doi: 10.1038/s41433-023-02535-7.
Hassan B, Ahmed R, Li B, Noor A, Hassan ZU. A comprehensive study capturing vision loss burden in Pakistan (1990-2025): Findings from the Global Burden of Disease (GBD) 2017 study. PloS One. 2019 May; 14(5): e0216492. doi: 10.1371/journal.pone.0216492.
Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Scientific Reports. 2021 Jul; 11(1): 13762. doi: 10.1038/s41598-021-92971-w.
Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020 Nov; 12(11). doi: 10.7759/cureus.11686.
Steinmetz JD, Bourne RR, Briant PS, Flaxman SR, Taylor HR, Jonas JB, Abdoli AA, Abrha WA, Abualhasan A, Abu-Gharbieh EG, Adal TG. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. The Lancet Global Health. 2021 Feb; 9(2): e144-60.
Lee SS and Mackey DA. Glaucoma–risk factors and current challenges in the diagnosis of a leading cause of visual impairment. Maturitas. 2022 Sep; 163: 15-22. doi: 10.1016/j.maturitas.2022.05.002.
Olawoye O, Kizor-Akaraiwe N, Pons J, Sarimiye T, Washaya J, Hughes S et al. Clinical characteristics and stage at presentation of glaucoma patients in Sub-Saharan Africa. Journal of glaucoma. 2022 Sep; 31(9): 717-23. doi: 10.1097/IJG.0000000000002068.
McMonnies CW. Glaucoma history and risk factors. Journal of Optometry. 2017 Apr; 10(2): 71-8. doi: 10.1016%2Fj.optom.2016.02.003.
Gasch AT, Wang P, Pasquale LR. Determinants of glaucoma awareness in a general eye clinic. Ophthalmology. 2000 Feb; 107(2): 303-8. doi: 10.1016/s0161-6420(99)00076-7.
Celebi AR. Knowledge and awareness of glaucoma in subjects with glaucoma and their normal first-degree relatives. Medical Hypothesis, Discovery and Innovation in Ophthalmology. 2018; 7(1): 40.
Ve Ramesh S, Pradeep PG, George R, Mani B, Arvind H, Madan RV et al. Determinants of glaucoma awareness and knowledge in urban Chennai. Indian Journal of Ophthalmology. 2009 Nov; 57(5). doi: 10.4103/0301-4738.55073.
Kazmi S, Jabeen A, Gul R. Rising glaucoma burden in Pakistan: A wake-up call for nationwide screening?. JPMA. The Journal of the Pakistan Medical Association. 2022 May;72(5):1016. doi: 10.47391/JPMA.3722.
Danni S and Lin D. Risk factors for primary glaucoma. International Review of Ophthalmology. 2019 Jun; 43(3): 194.
Ng Yin Ling C, Lim SC, Jonas JB, Sabanayagam C. Obesity and risk of age-related eye diseases: A systematic review of prospective population-based studies. International Journal of Obesity. 2021 Sep; 45(9): 1863-85. doi: 10.1038/s41366-021-00829-y.
McNaught AI, Allen JG, Healey DL, McCartney PJ, Coote MA, Wong TL et al. Accuracy and implications of a reported family history of glaucoma: experience from the Glaucoma Inheritance Study in Tasmania. Archives of ophthalmology. 2000 Jul; 118(7): 900-4. doi: 10-1001/pubs.Ophthalmol.-ISSN-0003-9950-118-7-ecs90101.
Soqia J, Ataya J, Alhalabi R, Alhomsi R, Hamwy R, Mardini K et al. Awareness and knowledge of glaucoma among visitors of main public hospitals in Damascus, Syria: a cross-sectional study. BMC Ophthalmology. 2023 Jan; 23(1): 17. doi: 10.1186/s12886-022-02766-4.
Bodunde OT, Daniel OJ, Onabolu OO. Knowledge, attitude and health believes of glaucoma patients in a Nigerian hospital. Niger Med Pract. 2006; 50: 62-4. doi: 10.4314/nmp.v50i3.28871.
Komolafe OO, Omolase CO, Bekibele CO, Ogunleye OA, Komolafe OA, Omotayo FO. Awareness and knowledge of glaucoma among workers in a Nigerian tertiary health care institution. Middle East African Journal of Ophthalmology. 2013 Apr; 20(2): 163. doi: 10.4103%2F0974-9233.110609.
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. Jama. 2014 May; 311(18): 1901-11. doi: 10.1001%2Fjama.2014.3192.
Safitri A, Konstantakopoulou E, Hu K, Gazzard G. Treatment expectations in glaucoma: what matters most to patients?. Eye. 2023 Apr 24: 1-9. doi: 10.1038/s41433-023-02532-w.
Soh Z, Yu M, Betzler BK, Majithia S, Thakur S, Tham YC et al. The global extent of undetected glaucoma in adults: a systematic review and meta-analysis. Ophthalmology. 2021 Oct; 128(10): 1393-404. doi: 10.1016/j.ophtha.2021.04.009.
Gebremariam MG, Bacha RH, Demissie DK, Wolde KS, Dame KT, Akessa GM. Modeling Time to Blindness of Glaucoma Patients: A Case Study at Jimma University Medical Center. Journal of Research in Health Sciences. 2022; 22(2): e00548. doi: 10.34172%2Fjrhs.2022.83.
Allison K, Patel D, Besharim C, Besharim CR. The value of annual glaucoma screening for high-risk adults ages 60 to 80. Cureus. 2021 Oct 12;13(10). doi: 10.7759%2Fcureus.18710.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 THE THERAPIST (Journal of Therapies & Rehabilitation Sciences)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@thetherapist.com.pk